CLINICAL CASE OF TREATMENT WITH RIBOSOMAL COMPLEX IN CHILD WITH COMPROMISED IMMUNITY

<em>The leading pathology in children is acute respiratory infections (ARI) according to the expert data of WHO. The incidence of prolonged and recurrent types of ARI increases during recent years. Patients with these diseases subsequently form the group of children with compromised immunity....

Full description

Bibliographic Details
Main Authors: A.A. Alekseeva, Yu.G. Levina, R.M. Torshkhoeva, E.A. Vishneva
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2011-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/594
Description
Summary:<em>The leading pathology in children is acute respiratory infections (ARI) according to the expert data of WHO. The incidence of prolonged and recurrent types of ARI increases during recent years. Patients with these diseases subsequently form the group of children with compromised immunity. Immunogens and immunomodulators are the drugs of nonspecific prophylaxis which are used for the prevention of ARI. The group of bacterial immunomodulators is big but most well-studied systemic drug from this group is Ribomunyl. Ribosomal complex is effective and safe in pediatric practice. The article presents the clinical case of treatment with ribosomal complex in immunocompronised child with allergic pathology.</em><br /><strong><em>Key words: children with compromised immunity, allergy, acute respiratory infections, treatment.</em></strong><br /><span style="text-decoration: underline;"><em><em>(Voprosy sovremennoi pediatrii — Current Pediatrics. </em></em><em><em>2011; 10 (2): 211–215)</em></em></span>
ISSN:1682-5527
1682-5535